Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2003 Feb 1;369(Pt 3):687–695. doi: 10.1042/BJ20021509

Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone.

Mark J Holness 1, Karen Bulmer 1, Nicholas D Smith 1, Mary C Sugden 1
PMCID: PMC1223128  PMID: 12435272

Abstract

Liver contains two pyruvate dehydrogenase kinases (PDKs), namely PDK2 and PDK4, which regulate glucose oxidation through inhibitory phosphorylation of the pyruvate dehydrogenase complex (PDC). Starvation increases hepatic PDK2 and PDK4 protein expression, the latter occurring, in part, via a mechanism involving peroxisome proliferator-activated receptor-alpha (PPARalpha). High-fat feeding and hyperthyroidism, which increase circulating lipid supply, enhance hepatic PDK2 protein expression, but these increases are insufficient to account for observed increases in hepatic PDK activity. Enhanced expression of PDK4, but not PDK2, occurs in part via a mechanism involving PPAR-alpha. Heterodimerization partners for retinoid X receptors (RXRs) include PPARalpha and thyroid-hormone receptors (TRs). We therefore investigated the responses of hepatic PDK protein expression to high-fat feeding and hyperthyroidism in relation to hepatic lipid delivery and disposal. High-fat feeding increased hepatic PDK2, but not PDK4, protein expression whereas hyperthyroidism increased both hepatic PDK2 and PDK4 protein expression. Both manipulations decreased the sensitivity of hepatic carnitine palmitoyltransferase I (CPT I) to suppression by malonyl-CoA, but only hyperthyrodism elevated plasma fatty acid and ketone-body concentrations and CPT I maximal activity. Administration of the selective PPAR-alpha activator WY14,643 significantly increased PDK4 protein to a similar extent in both control and high-fat-fed rats, but WY14,643 treatment and hyperthyroidism did not have additive effects on hepatic PDK4 protein expression. PPARalpha activation did not influence hepatic PDK2 protein expression in euthyroid rats, suggesting that up-regulation of PDK2 by hyperthyroidism does not involve PPARalpha, but attenuated the effect of hyperthyroidism to increase hepatic PDK2 expression. The results indicate that hepatic PDK4 up-regulation can be achieved by heterodimerization of either PPARalpha or TR with the RXR receptor and that effects of PPARalpha activation on hepatic PDK2 and PDK4 expression favour a switch towards preferential expression of PDK4.

Full Text

The Full Text of this article is available as a PDF (249.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bowker-Kinley M. M., Davis W. I., Wu P., Harris R. A., Popov K. M. Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex. Biochem J. 1998 Jan 1;329(Pt 1):191–196. doi: 10.1042/bj3290191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brass E. P., Hoppel C. L. Carnitine metabolism in the fasting rat. J Biol Chem. 1978 Apr 25;253(8):2688–2693. [PubMed] [Google Scholar]
  3. Brun S., Carmona M. C., Mampel T., Viñas O., Giralt M., Iglesias R., Villarroya F. Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth. Diabetes. 1999 Jun;48(6):1217–1222. doi: 10.2337/diabetes.48.6.1217. [DOI] [PubMed] [Google Scholar]
  4. Caterson I. D., Fuller S. J., Randle P. J. Effect of the fatty acid oxidation inhibitor 2-tetradecylglycidic acid on pyruvate dehydrogenase complex activity in starved and alloxan-diabetic rats. Biochem J. 1982 Oct 15;208(1):53–60. doi: 10.1042/bj2080053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chu R., Madison L. D., Lin Y., Kopp P., Rao M. S., Jameson J. L., Reddy J. K. Thyroid hormone (T3) inhibits ciprofibrate-induced transcription of genes encoding beta-oxidation enzymes: cross talk between peroxisome proliferator and T3 signaling pathways. Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11593–11597. doi: 10.1073/pnas.92.25.11593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Denyer G. S., Kerbey A. L., Randle P. J. Kinase activator protein mediates longer-term effects of starvation on activity of pyruvate dehydrogenase kinase in rat liver mitochondria. Biochem J. 1986 Oct 15;239(2):347–354. doi: 10.1042/bj2390347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Drynan L., Quant P. A., Zammit V. A. The role of changes in the sensitivity of hepatic mitochondrial overt carnitine palmitoyltransferase in determining the onset of the ketosis of starvation in the rat. Biochem J. 1996 Sep 15;318(Pt 3):767–770. doi: 10.1042/bj3180767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fatania H. R., Vary T. C., Randle P. J. Modulation of pyruvate dehydrogenase kinase activity in cultured hepatocytes by glucagon and n-octanoate. Biochem J. 1986 Feb 15;234(1):233–236. doi: 10.1042/bj2340233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Forman B. M., Chen J., Evans R. M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4312–4317. doi: 10.1073/pnas.94.9.4312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fryer L. G., Holness M. J., Sugden M. C. Selective modification of insulin action in adipose tissue by hyperthyroidism. J Endocrinol. 1997 Sep;154(3):513–522. doi: 10.1677/joe.0.1540513. [DOI] [PubMed] [Google Scholar]
  11. Gearing K. L., Göttlicher M., Widmark E., Banner C. D., Tollet P., Strömstedt M., Rafter J. J., Berge R. K., Gustafsson J. A. Fatty acid activation of the peroxisome proliferator activated receptor, a member of the nuclear receptor gene superfamily. J Nutr. 1994 Aug;124(8 Suppl):1284S–1288S. doi: 10.1093/jn/124.suppl_8.1284S. [DOI] [PubMed] [Google Scholar]
  12. Grantham B. D., Zammit V. A. Restoration of the properties of carnitine palmitoyltransferase I in liver mitochondria during re-feeding of starved rats. Biochem J. 1986 Oct 15;239(2):485–488. doi: 10.1042/bj2390485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Harris R. A., Huang B., Wu P. Control of pyruvate dehydrogenase kinase gene expression. Adv Enzyme Regul. 2001;41:269–288. doi: 10.1016/s0065-2571(00)00020-0. [DOI] [PubMed] [Google Scholar]
  14. Harris R. A., Popov K. M., Zhao Y. Nutritional regulation of the protein kinases responsible for the phosphorylation of the alpha-ketoacid dehydrogenase complexes. J Nutr. 1995 Jun;125(6 Suppl):1758S–1761S. [PubMed] [Google Scholar]
  15. Hertz R., Nikodem V., Ben-Ishai A., Berman I., Bar-Tana J. Thyromimetic mode of action of peroxisome proliferators: activation of 'malic' enzyme gene transcription. Biochem J. 1996 Oct 1;319(Pt 1):241–248. doi: 10.1042/bj3190241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Holness M. J., Kraus A., Harris R. A., Sugden M. C. Targeted upregulation of pyruvate dehydrogenase kinase (PDK)-4 in slow-twitch skeletal muscle underlies the stable modification of the regulatory characteristics of PDK induced by high-fat feeding. Diabetes. 2000 May;49(5):775–781. doi: 10.2337/diabetes.49.5.775. [DOI] [PubMed] [Google Scholar]
  17. Holness M. J., MacLennan P. A., Palmer T. N., Sugden M. C. The disposition of carbohydrate between glycogenesis, lipogenesis and oxidation in liver during the starved-to-fed transition. Biochem J. 1988 Jun 1;252(2):325–330. doi: 10.1042/bj2520325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Holness M. J., Sugden M. C. Antecedent protein restriction exacerbates development of impaired insulin action after high-fat feeding. Am J Physiol. 1999 Jan;276(1 Pt 1):E85–E93. doi: 10.1152/ajpendo.1999.276.1.E85. [DOI] [PubMed] [Google Scholar]
  19. Huang Boli, Wu Pengfei, Bowker-Kinley Melissa M., Harris Robert A. Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin. Diabetes. 2002 Feb;51(2):276–283. doi: 10.2337/diabetes.51.2.276. [DOI] [PubMed] [Google Scholar]
  20. Jones B. S., Yeaman S. J., Sugden M. C., Holness M. J. Hepatic pyruvate dehydrogenase kinase activities during the starved-to-fed transition. Biochim Biophys Acta. 1992 Mar 16;1134(2):164–168. doi: 10.1016/0167-4889(92)90040-i. [DOI] [PubMed] [Google Scholar]
  21. Keller H., Dreyer C., Medin J., Mahfoudi A., Ozato K., Wahli W. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2160–2164. doi: 10.1073/pnas.90.6.2160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kerbey A. L., Radcliffe P. M., Randle P. J. Diabetes and the control of pyruvate dehydrogenase in rat heart mitochondria by concentration ratios of adenosine triphosphate/adenosine diphosphate, of reduced/oxidized nicotinamide-adenine dinucleotide and of acetyl-coenzyme A/coenzyme A. Biochem J. 1977 Jun 15;164(3):509–519. doi: 10.1042/bj1640509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kerbey A. L., Randle P. J. Pyruvate dehydrogenase kinase/activator in rat heart mitochondria, Assay, effect of starvation, and effect of protein-synthesis inhibitors of starvation. Biochem J. 1982 Jul 15;206(1):103–111. doi: 10.1042/bj2060103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kersten S., Desvergne B., Wahli W. Roles of PPARs in health and disease. Nature. 2000 May 25;405(6785):421–424. doi: 10.1038/35013000. [DOI] [PubMed] [Google Scholar]
  25. Kliewer S. A., Sundseth S. S., Jones S. A., Brown P. J., Wisely G. B., Koble C. S., Devchand P., Wahli W., Willson T. M., Lenhard J. M. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4318–4323. doi: 10.1073/pnas.94.9.4318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kraegen E. W., James D. E., Jenkins A. B., Chisholm D. J., Storlien L. H. A potent in vivo effect of ciglitazone on muscle insulin resistance induced by high fat feeding of rats. Metabolism. 1989 Nov;38(11):1089–1093. doi: 10.1016/0026-0495(89)90045-0. [DOI] [PubMed] [Google Scholar]
  27. Le May C., Pineau T., Bigot K., Kohl C., Girard J., Pégorier J. P. Reduced hepatic fatty acid oxidation in fasting PPARalpha null mice is due to impaired mitochondrial hydroxymethylglutaryl-CoA synthase gene expression. FEBS Lett. 2000 Jun 23;475(3):163–166. doi: 10.1016/s0014-5793(00)01648-3. [DOI] [PubMed] [Google Scholar]
  28. Leone T. C., Weinheimer C. J., Kelly D. P. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7473–7478. doi: 10.1073/pnas.96.13.7473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Liu H. C., Towle H. C. Functional synergism between multiple thyroid hormone response elements regulates hepatic expression of the rat S14 gene. Mol Endocrinol. 1994 Aug;8(8):1021–1037. doi: 10.1210/mend.8.8.7997231. [DOI] [PubMed] [Google Scholar]
  30. Marchington D. R., Kerbey A. L., Giardina M. G., Jones A. E., Randle P. J. Longer-term regulation of pyruvate dehydrogenase kinase in cultured rat hepatocytes. Biochem J. 1989 Jan 15;257(2):487–491. doi: 10.1042/bj2570487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. McGarry J. D., Brown N. F. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem. 1997 Feb 15;244(1):1–14. doi: 10.1111/j.1432-1033.1997.00001.x. [DOI] [PubMed] [Google Scholar]
  32. Mynatt R. L., Park E. A., Thorngate F. E., Das H. K., Cook G. A. Changes in carnitine palmitoyltransferase-I mRNA abundance produced by hyperthyroidism and hypothyroidism parallel changes in activity. Biochem Biophys Res Commun. 1994 Jun 15;201(2):932–937. doi: 10.1006/bbrc.1994.1791. [DOI] [PubMed] [Google Scholar]
  33. Orfali K. A., Fryer L. G., Holness M. J., Sugden M. C. Interactive effects of insulin and triiodothyronine on pyruvate dehydrogenase kinase activity in cardiac myocytes. J Mol Cell Cardiol. 1995 Mar;27(3):901–908. doi: 10.1016/0022-2828(95)90040-3. [DOI] [PubMed] [Google Scholar]
  34. Peters S. J., Harris R. A., Heigenhauser G. J., Spriet L. L. Muscle fiber type comparison of PDH kinase activity and isoform expression in fed and fasted rats. Am J Physiol Regul Integr Comp Physiol. 2001 Mar;280(3):R661–R668. doi: 10.1152/ajpregu.2001.280.3.R661. [DOI] [PubMed] [Google Scholar]
  35. Pineda Torra I., Gervois P., Staels B. Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging. Curr Opin Lipidol. 1999 Apr;10(2):151–159. doi: 10.1097/00041433-199904000-00009. [DOI] [PubMed] [Google Scholar]
  36. Popov K. M., Hawes J. W., Harris R. A. Mitochondrial alpha-ketoacid dehydrogenase kinases: a new family of protein kinases. Adv Second Messenger Phosphoprotein Res. 1997;31:105–111. [PubMed] [Google Scholar]
  37. Priestman D. A., Donald E., Holness M. J., Sugden M. C. Different mechanisms underlie the long-term regulation of pyruvate dehydrogenase kinase (PDHK) by tri-iodothyronine in heart and liver. FEBS Lett. 1997 Dec 8;419(1):55–57. doi: 10.1016/s0014-5793(97)01430-0. [DOI] [PubMed] [Google Scholar]
  38. Priestman D. A., Mistry S. C., Halsall A., Randle P. J. Role of protein synthesis and of fatty acid metabolism in the longer-term regulation of pyruvate dehydrogenase kinase. Biochem J. 1994 Jun 15;300(Pt 3):659–664. doi: 10.1042/bj3000659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Ren B., Thelen A. P., Peters J. M., Gonzalez F. J., Jump D. B. Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha. J Biol Chem. 1997 Oct 24;272(43):26827–26832. doi: 10.1074/jbc.272.43.26827. [DOI] [PubMed] [Google Scholar]
  40. Ren B., Thelen A., Jump D. B. Peroxisome proliferator-activated receptor alpha inhibits hepatic S14 gene transcription. Evidence against the peroxisome proliferator-activated receptor alpha as the mediator of polyunsaturated fatty acid regulation of s14 gene transcription. J Biol Chem. 1996 Jul 19;271(29):17167–17173. doi: 10.1074/jbc.271.29.17167. [DOI] [PubMed] [Google Scholar]
  41. Rennie M. J., Winder W. W., Holloszy J. O. A sparing effect of increased plasma fatty acids on muscle and liver glycogen content in the exercising rat. Biochem J. 1976 Jun 15;156(3):647–655. doi: 10.1042/bj1560647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Roche T. E., Baker J. C., Yan X., Hiromasa Y., Gong X., Peng T., Dong J., Turkan A., Kasten S. A. Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms. Prog Nucleic Acid Res Mol Biol. 2001;70:33–75. doi: 10.1016/s0079-6603(01)70013-x. [DOI] [PubMed] [Google Scholar]
  43. Schofield P. S., French T. J., Goode A. W., Sugden M. C. Liver carnitine metabolism after partial hepatectomy in the rat. Effects of nutritional status and inhibition of carnitine palmitoyltransferase. FEBS Lett. 1985 May 20;184(2):214–220. doi: 10.1016/0014-5793(85)80609-8. [DOI] [PubMed] [Google Scholar]
  44. Sleboda J., Risan K. A., Spydevold O., Bremer J. Short-term regulation of carnitine palmitoyltransferase I in cultured rat hepatocytes: spontaneous inactivation and reactivation by fatty acids. Biochim Biophys Acta. 1999 Jan 4;1436(3):541–549. doi: 10.1016/s0005-2760(98)00164-7. [DOI] [PubMed] [Google Scholar]
  45. Stakkestad J. A., Bremer J. The outer carnitine palmitoyltransferase and regulation of fatty acid metabolism in rat liver in different thyroid states. Biochim Biophys Acta. 1983 Feb 7;750(2):244–252. doi: 10.1016/0005-2760(83)90025-5. [DOI] [PubMed] [Google Scholar]
  46. Sugden M. C., Bulmer K., Holness M. J. Fuel-sensing mechanisms integrating lipid and carbohydrate utilization. Biochem Soc Trans. 2001 May;29(Pt 2):272–278. doi: 10.1042/0300-5127:0290272. [DOI] [PubMed] [Google Scholar]
  47. Sugden M. C., Fryer L. G., Orfali K. A., Priestman D. A., Donald E., Holness M. J. Studies of the long-term regulation of hepatic pyruvate dehydrogenase kinase. Biochem J. 1998 Jan 1;329(Pt 1):89–94. doi: 10.1042/bj3290089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Sugden M. C., Fryer L. G., Priestman D. A., Orfali K. A., Holness M. J. Increased hepatic pyruvate dehydrogenase kinase activity in fed hyperthyroid rats: studies in vivo and with cultured hepatocytes. Mol Cell Endocrinol. 1996 May 31;119(2):219–224. doi: 10.1016/0303-7207(96)03817-8. [DOI] [PubMed] [Google Scholar]
  49. Sugden M. C., Holness M. J. Control of muscle pyruvate oxidation during late pregnancy. FEBS Lett. 1993 Apr 26;321(2-3):121–126. doi: 10.1016/0014-5793(93)80091-8. [DOI] [PubMed] [Google Scholar]
  50. Sugden M. C., Holness M. J. Interactive regulation of the pyruvate dehydrogenase complex and the carnitine palmitoyltransferase system. FASEB J. 1994 Jan;8(1):54–61. doi: 10.1096/fasebj.8.1.8299890. [DOI] [PubMed] [Google Scholar]
  51. Sugden M. C., Langdown M. L., Harris R. A., Holness M. J. Expression and regulation of pyruvate dehydrogenase kinase isoforms in the developing rat heart and in adulthood: role of thyroid hormone status and lipid supply. Biochem J. 2000 Dec 15;352(Pt 3):731–738. [PMC free article] [PubMed] [Google Scholar]
  52. Sugden M. C., Priestman D. A., Orfali K. A., Holness M. J. Hyperthyroidism facilitates cardiac fatty acid oxidation through altered regulation of cardiac carnitine palmitoyltransferase: studies in vivo and with cardiac myocytes. Horm Metab Res. 1999 May;31(5):300–306. doi: 10.1055/s-2007-978741. [DOI] [PubMed] [Google Scholar]
  53. Sugden Mary C., Bulmer Karen, Gibbons Geoffrey F., Knight Brian L., Holness Mark J. Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin. Biochem J. 2002 Jun 1;364(Pt 2):361–368. doi: 10.1042/BJ20011699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Wu P., Blair P. V., Sato J., Jaskiewicz J., Popov K. M., Harris R. A. Starvation increases the amount of pyruvate dehydrogenase kinase in several mammalian tissues. Arch Biochem Biophys. 2000 Sep 1;381(1):1–7. doi: 10.1006/abbi.2000.1946. [DOI] [PubMed] [Google Scholar]
  55. Wu P., Peters J. M., Harris R. A. Adaptive increase in pyruvate dehydrogenase kinase 4 during starvation is mediated by peroxisome proliferator-activated receptor alpha. Biochem Biophys Res Commun. 2001 Sep 21;287(2):391–396. doi: 10.1006/bbrc.2001.5608. [DOI] [PubMed] [Google Scholar]
  56. Wu P., Sato J., Zhao Y., Jaskiewicz J., Popov K. M., Harris R. A. Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart. Biochem J. 1998 Jan 1;329(Pt 1):197–201. doi: 10.1042/bj3290197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Yu K., Bayona W., Kallen C. B., Harding H. P., Ravera C. P., McMahon G., Brown M., Lazar M. A. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem. 1995 Oct 13;270(41):23975–23983. doi: 10.1074/jbc.270.41.23975. [DOI] [PubMed] [Google Scholar]
  58. Zammit V. A. Time-dependence of inhibition of carnitine palmitoyltransferase I by malonyl-CoA in mitochondria isolated from livers of fed or starved rats. Evidence for transition of the enzyme between states of low and high affinity for malonyl-CoA. Biochem J. 1984 Mar 1;218(2):379–386. doi: 10.1042/bj2180379. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES